New Delhi, June 10 -- Mid-cap pharma stock Akum Drugs has been rebounding well, rising almost 35% from April lows amid renewed strength in the domestic stock market.

Akums Drugs and Pharmaceuticals' share price has seen sharp gains of almost 35% from closing lows of around Rs.421 seen on the BSE on April 7, 2025, to Rs.568 levels now. The stock had hit a 52-week low of Rs.407.40 in intraday trade on April 7, in line with the sharp correction in the markets following global uncertainties and tariffs imposed by US President Donald Trump.

ICICI Securities, post the pharma company's Q4 FY25 results, said that Akums Drugs and Pharmaceuticals' revenue was ahead of our expectation, though unfavourable product mix dented margins.

"The CDMO or ...